Cargando…
NTRK fusion in Japanese colorectal adenocarcinomas
NTRK fusion-positive tumors are known to be highly sensitive to TRK inhibitors, such as larotrectinib and entrectinib. Therefore, identification of patients who can potentially benefit from these inhibitors is important; however, the frequency of NTRK fusions in Japanese patients with colorectal can...
Autores principales: | Yamashiro, Yuya, Kurihara, Taisei, Hayashi, Takuo, Suehara, Yoshiyuki, Yao, Takashi, Kato, Shunsuke, Saito, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952565/ https://www.ncbi.nlm.nih.gov/pubmed/33707574 http://dx.doi.org/10.1038/s41598-021-85075-y |
Ejemplares similares
-
Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors
por: Kurihara, Taisei, et al.
Publicado: (2020) -
RETRACTED ARTICLE: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2021) -
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2022) -
Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2022) -
PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma
por: Akaike, Keisuke, et al.
Publicado: (2018)